Cell Therapy Products
Cell Culture Products
Advancing new possibilities in care
Some medical conditions continue to challenge conventional treatment approaches.
Regenerative medicine opens the door to new therapeutic possibilities by harnessing the potential of cells and advanced biotechnologies to support repair and recovery.
At NIPRO, regenerative medicine is a natural extension of our commitment to improving lives through innovation. As a trusted global healthcare partner with decades of experience in medical technologies and patient care, we continue to push boundaries together with healthcare professionals, researchers, and academic partners around the world.
By combining scientific collaboration with advanced manufacturing expertise, we aim to help shape the future of regenerative healthcare and create meaningful impact for patients.
From development to delivery
Regenerative medicine requires more than scientific innovation alone. It depends on highly controlled manufacturing environments, advanced sterile processing, and precise long-term cell culture technologies.
NIPRO supports regenerative medicine across the entire value chain — from development and manufacturing to market delivery. This integrated approach allows us to provide consistent quality and reliability throughout every stage of the process.
Built on integrated expertise
The production of regenerative medicine therapies requires strict compliance with standards such as GCTP and GMP. Materials and equipment used throughout the manufacturing process — including cell culture containers, culture media, preservation containers, and manufacturing facilities — must meet demanding quality and sterility requirements.
One of NIPRO’s strengths lies in our ability to develop and supply many of these critical components in-house. Combined with our experience in sterile manufacturing and established quality management systems, this provides a strong foundation for our regenerative medicine activities.
Supporting the future of regenerative therapies
As regenerative medicine continues to evolve, NIPRO remains focused on expanding treatment possibilities and supporting the advancement of innovative therapies. Ongoing efforts include advancing therapies such as STEMIRAC® Injection into additional applications, including chronic spinal cord injury and ALS.
By continuously strengthening our technologies, collaborative networks, and manufacturing capabilities, we aim to contribute to the future of regenerative healthcare and help bring innovative therapies to more patients worldwide.